-
Je něco špatně v tomto záznamu ?
Gadolinium alginate nanogels for theranostic applications
K. Podgórna, K. Szczepanowicz, M. Piotrowski, M. Gajdošová, F. Štěpánek, P. Warszyński,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- algináty chemie MeSH
- buněčná smrt MeSH
- fluorescenční barviva chemie MeSH
- gadolinium chemie MeSH
- lidé MeSH
- magnetická rezonanční tomografie MeSH
- nádorové buněčné linie MeSH
- polyethylenglykoly chemická syntéza chemie MeSH
- polyethylenimin chemická syntéza chemie MeSH
- teranostická nanomedicína * MeSH
- viabilita buněk MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Synthesis of theranostic nanoparticles, which combine both therapeutic and diagnostic capabilities in one platform can be considered as a step forward personalized medicine, since it allows tracing the delivery of the drug to targeted organ. Thus, the aim of this work was to prepare gadolinium alginate gel nanoparticles (gadolinum nanogels - GdNG) by the reverse microemulsions and physical crosslinking method as the vehicles able to carry hydrophilic drugs and to be traced by the Magnetic Resonance Imaging (MRI). The average size of synthesized nanoparticles was about 110nm and the batch concentration was 10(10) particles/ml. The morphology of nanogeles was visualized by Cryo-Scanning Electron Microscopy. Surface of nanogels particles was modified by the Layer-by-Layer (LbL) technique using natural polyelectrolytes. The cytotoxicity of non-modified and LbL modified nanogels was evaluated by the cellular viability quantification and cell death assessments using MTT and LDH biochemical tests, respectively. We encapsulated the model compound - fluorescent dye (Rhodamine b) in nanogels networks and proved the possibility of GdNG visualization by MRI.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17023251
- 003
- CZ-PrNML
- 005
- 20170830115602.0
- 007
- ta
- 008
- 170720s2017 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.colsurfb.2017.02.026 $2 doi
- 035 __
- $a (PubMed)28242371
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Podgórna, K $u Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, PL-30239, Krakow, Poland. Electronic address: ncpodgor@cyf-kr.edu.pl.
- 245 10
- $a Gadolinium alginate nanogels for theranostic applications / $c K. Podgórna, K. Szczepanowicz, M. Piotrowski, M. Gajdošová, F. Štěpánek, P. Warszyński,
- 520 9_
- $a Synthesis of theranostic nanoparticles, which combine both therapeutic and diagnostic capabilities in one platform can be considered as a step forward personalized medicine, since it allows tracing the delivery of the drug to targeted organ. Thus, the aim of this work was to prepare gadolinium alginate gel nanoparticles (gadolinum nanogels - GdNG) by the reverse microemulsions and physical crosslinking method as the vehicles able to carry hydrophilic drugs and to be traced by the Magnetic Resonance Imaging (MRI). The average size of synthesized nanoparticles was about 110nm and the batch concentration was 10(10) particles/ml. The morphology of nanogeles was visualized by Cryo-Scanning Electron Microscopy. Surface of nanogels particles was modified by the Layer-by-Layer (LbL) technique using natural polyelectrolytes. The cytotoxicity of non-modified and LbL modified nanogels was evaluated by the cellular viability quantification and cell death assessments using MTT and LDH biochemical tests, respectively. We encapsulated the model compound - fluorescent dye (Rhodamine b) in nanogels networks and proved the possibility of GdNG visualization by MRI.
- 650 _2
- $a algináty $x chemie $7 D000464
- 650 _2
- $a buněčná smrt $7 D016923
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a viabilita buněk $7 D002470
- 650 _2
- $a fluorescenční barviva $x chemie $7 D005456
- 650 _2
- $a gadolinium $x chemie $7 D005682
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a polyethylenglykoly $x chemická syntéza $x chemie $7 D011092
- 650 _2
- $a polyethylenimin $x chemická syntéza $x chemie $7 D011094
- 650 12
- $a teranostická nanomedicína $7 D000068936
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Szczepanowicz, K $u Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, PL-30239, Krakow, Poland.
- 700 1_
- $a Piotrowski, M $u Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, PL-30239, Krakow, Poland.
- 700 1_
- $a Gajdošová, M $u University of Chemistry and Technology, Technická 3, 166 28, Prague, Czechia.
- 700 1_
- $a Štěpánek, F $u University of Chemistry and Technology, Technická 3, 166 28, Prague, Czechia.
- 700 1_
- $a Warszyński, P $u Jerzy Haber Institute of Catalysis and Surface Chemistry, Polish Academy of Sciences, Niezapominajek 8, PL-30239, Krakow, Poland.
- 773 0_
- $w MED00180202 $t Colloids and surfaces. B, Biointerfaces $x 1873-4367 $g Roč. 153, č. - (2017), s. 183-189
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28242371 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170720 $b ABA008
- 991 __
- $a 20170830120151 $b ABA008
- 999 __
- $a ok $b bmc $g 1238932 $s 984164
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 153 $c - $d 183-189 $e 20170221 $i 1873-4367 $m Colloids and surfaces. B, Biointerfaces $n Colloids surf., B Biointerfaces $x MED00180202
- LZP __
- $a Pubmed-20170720